Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Fecal microbiome alterations in treatment-naive de novo Parkinson's disease (2022)
- NPJ Parkinson's diseaseErikoislääkäri
- (2022)
- Movement DisordersDuodecim
- Height and nigral neuron density in Parkinson's disease2022
- BMC Neurology
- Lääkeparkinsonismi (2022)
- Duodecim
- MS-taudin ja liikehäiriöiden laaturekisteritSubthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow-up to 10 years (2022)
- Parkinsonin taudin epidemiologia ja genetiikka Suomessa (2022)
- (2022)
- Movement Disorders Clinical PracticeDuodecim
- Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study (2022)
- Parkinsonism and Related Disorders
- (2022)
- Brain and BehaviorNeuroImage
- The neural substrates of risky rewards and losses in healthy volunteers and patient groups: A PET imaging study (2022)
- Psychological Medicine
- Toiminnallisten raajapareesien ja liikehäiriöiden kliininen tutkiminen (2022)
- (2022)
- LääkärilehtiAnnals of Neurology
- (2021) Lääkärin käsikirja Kaasinen Valtteri
- Cerebral grey matter density is associated with neuroreceptor and neurotransporter availability: A combined PET and MRI study (2021)
- Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior (2021)
- Translational Psychiatry
- Depression and Nigral Neuron Density in Lewy Body Spectrum Diseases (2021)
- 2021
- Journal of Neural Transmission
- Dopamine Receptors in Parkinson's Disease: A Meta-Analysis of Imaging Studies (2021)
- Movement Disorders
- Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials (2021)
- NeuroImage: Clinical
- Essentiaalinen vapina (2021) Lääkärin käsikirja Kaasinen Valtteri



